Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sango, Junya"'
Autor:
Kakihana, Taichi, Takahashi, Masahiko, Katsuragi, Yoshinori, Yamashita, Shun-Ichi, Sango, Junya, Kanki, Tomotake, Onodera, Osamu, Fujii, Masahiro
Publikováno v:
In iScience 23 July 2021 24(7)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sango, Junya, Carcamo, Saul, Sirenko, Maria, Maiti, Abhishek, Mansour, Hager, Ulukaya, Gulay, Tomalin, Lewis, Olivier, Emmanuel, Olszewska, Malgorzata, Demircioglu, Deniz, Landau, Dan, Papaemmanuil, Elli, DiNardo, Courtney, Hasson, Dan, Konopleva, Marina, Papapetrou, Eirini
Publikováno v:
In Experimental Hematology August 2024 137 Supplement
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sango, Junya
Nrf2 is an antioxidant transcriptional activator in many types of cells, and its dysfunction plays key roles in a variety of human disorders, including Parkinson's disease (PD). PD is characterized by the selective loss of dopaminergic neurons in PD-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::dec49b195f30b4e677069874bb7dedec
https://niigata-u.repo.nii.ac.jp/records/2000864
https://niigata-u.repo.nii.ac.jp/records/2000864
Autor:
Waarts MR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Mowla S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Boileau M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Martinez Benitez AR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Sango J; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Center for Advancement of Blood Cancer Therapies, Institute for Regenerative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Bagish M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Fernández-Maestre I; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Shan Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Eisman SE; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Park YC; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Wereski M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Csete I; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., O'Connor K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Romero-Vega AC; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Miles LA; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio., Xiao W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Wu X; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Shih AH; Division of Hematology Oncology, Department of Medicine, Tisch Cancer Institute (TCI), Icahn School of Medicine at Mount Sinai, New York, New York., Papapetrou EP; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Center for Advancement of Blood Cancer Therapies, Institute for Regenerative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Butler JM; Department of Medicine, University of Florida Health Cancer Center, Gainesville, Florida., Cai SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Bowman RL; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Oct 04; Vol. 14 (10), pp. 1860-1878.